StockSignal
  • Screen for fundamentally interesting stocks
Sign in

LivsMed Inc.

491000 · XKRX · Medical Devices · South Korea

Market Capitalization2.11T KRW
52-Week Change35.52 KRW

LivsMed Inc. is a medical device company specializing in advanced tools for minimally invasive surgery. The company develops and manufactures articulating laparoscopic instruments designed to enhance surgical precision while maintaining a cost structure closer to conventional laparoscopy. Its flagship ArtiSential line features single-use, wristed instruments with double-jointed end effectors that mirror a surgeon’s natural hand and wrist movements, offering multiple degrees of freedom at the instrument tip and preserving tactile feedback during procedures. LivsMed Inc. serves surgeons and hospitals focused on laparoscopic and robotic-assisted procedures across various specialties, including general, gastrointestinal, and other soft-tissue surgeries. By enabling fine control through ergonomic, fully articulating instruments without requiring major capital investment or changes to existing operating room infrastructure, LivsMed Inc. plays a role in broadening access to advanced minimally invasive techniques and supporting improvements in surgical efficiency and patient outcomes.

Industry

Medical Devices

Healthcare sector · South Korea

Stories

Structural patterns identified in LivsMed Inc.

No stories identified yet.

Key Metrics

Market Capitalization
2.11TKRW
NormalMar 18, 2026
Revenue (TTM)
44.16BKRW
NormalMar 18, 2026
Profit Margin
-46.01%
NormalMar 18, 2026
52-Week Change
35.52KRW
ExtremeMar 18, 2026

This company does not currently pay dividends.

Valuation6
Market Capitalization
2.11TKRW
NormalMar 18, 2026
Enterprise Value
1.86TKRW
NormalMar 18, 2026
Forward P/E
59.61KRW
AboveNormalMar 18, 2026
Price to Sales (TTM)
46.84KRW
AboveNormalMar 18, 2026
Enterprise to Revenue
42.01KRW
AboveNormalMar 18, 2026
Enterprise to EBITDA
-90.41KRW
ExtremeMar 18, 2026
Profitability & Growth10
Profit Margin
-46.01%
NormalMar 18, 2026
Operating Margin
-33.82%
BelowNormalMar 18, 2026
Revenue (TTM)
44.16BKRW
NormalMar 18, 2026
Revenue per Share (TTM)
2.12KKRW
NormalMar 18, 2026
Quarterly Revenue Growth
0.7160KRW
NormalMar 18, 2026
Gross Profit (TTM)
26.10BKRW
NormalMar 18, 2026
EBITDA
-20.52BKRW
ExtremeMar 18, 2026
Net Income (TTM)
-20.32BKRW
NormalMar 18, 2026
Operating Cash Flow (TTM)
-33.75BKRW
NormalMar 18, 2026
Levered Free Cash Flow (TTM)
0.00KRW
NormalMar 18, 2026
Financial Strength9
Shares Outstanding
24.68MShares
NormalMar 18, 2026
Float Shares
11.48MKRW
NormalMar 18, 2026
% Held by Insiders
0.4454KRW
NormalMar 18, 2026
% Held by Institutions
0.0019KRW
NormalMar 18, 2026
Total Cash (MRQ)
12.70BKRW
NormalMar 18, 2026
Total Cash per Share (MRQ)
572.80KRW
NormalMar 18, 2026
Total Debt (MRQ)
12.26BKRW
NormalMar 18, 2026
Total Debt to Equity (MRQ)
22.87KRW
ExtremeMar 18, 2026
Current Ratio (MRQ)
3.52KRW
AboveNormalMar 18, 2026
Market & Technical7
52-Week Low
46.25KKRW
NormalMar 18, 2026
52-Week High
95.90KKRW
NormalMar 18, 2026
52-Week Change
35.52KRW
ExtremeMar 18, 2026
50-Day MA
72.75KKRW
NormalMar 18, 2026
200-Day MA
71.86KKRW
NormalMar 18, 2026
Avg 10-Day Volume
709.50KKRW
NormalMar 18, 2026
Avg 30-Day Volume
845.29KKRW
NormalMar 18, 2026

Coordination

Placeholder CorpCoordination
Example HoldingsCoordination
Sample IncCoordination

Supply Chain

Medical Devices Supply Chain

The medical devices supply chain is shaped by three structural constraints that most manufacturing industries do not face: a regulatory classification cascade where risk level determines the years of validation required before a product can be sold, sterilization and biocompatibility requirements that restrict which materials and processes are permitted, and installed base dependency where hospitals commit to ecosystems that cannot be switched without replacing training, consumables, and data infrastructure.

StockSignal
  • Blog
  • Industries
  • Glossary
  • Stories
  • Coordinations
  • Constraint Archetypes
  • Legal

Contact

© 2026 StockSignal. All rights reserved.